New drug candidate ENA-001 takes first step in human trials
Knowledge-focused
Ongoing
This early-stage study tests the safety of a new drug called ENA-001 in 36 healthy volunteers. The drug is given as a single shot into a vein or muscle to see how the body handles it and if it causes any side effects. This research is a first step toward a possible treatment for …
Phase: PHASE1 • Sponsor: Enalare Therapeutics Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC